ArticleNature communications2026
Single-breath-hold 3D abdominal metabolic MRI enables label-free diagnosis of liver cancer.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Chemical exchange saturation transfer (CEST) MRI could detect proteins/peptides, creatine, glucose, and glycogen by labeling their exchangeable amide, amine, and hydroxyl groups respectively, via frequency-selective RF pulses. Without the need for contrast agents or specialized hardware, CEST can be conveniently integrated into existing clinical MR protocols. However, its abdominal application is limited by long scan time (> 5 min) and susceptibility to respiratory motion (60-70% successful scan rate). We develop an ultra-fast 3D CEST MRI approach using spatial-spectral encoding (SSE), enabling a full spectral scan of whole-liver 3D images within a single breath-hold. SSE-CEST employs an efficient z-ω encoding pattern by applying a saturation gradient, followed by a data-driven spatial spectral reconstruction based on the low-rankness of CEST spectra. SSE-CEST is comprehensively evaluated in glycogen phantoms, ex vivo porcine liver, healthy volunteers and patients. Single breath-hold SSE-CEST largely improves successful rate, with a correlation of 0.95 between two repeated scans. SSE-CEST enables the detection of multi-metabolite changes in the liver and pancreas after an overnight fasting, and the dynamic mapping of hepatic glucose metabolism during an oral glucose test. For liver cancer patients, SSE could differentiate active lesions from post-treatment necrosis, featuring superior in-slice spatial resolution and motion-stabilized images. SSE-CEST MRI potentially could facilitate the diagnosis and patient management for liver and other abdominal diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.